Zoetis (NYSE:ZTS) Stock Sale Reported by Rep. Byron Donalds

Representative Byron Donalds (Republican-Florida) recently sold shares of Zoetis Inc. (NYSE:ZTS). In a filing disclosed on November 16th, the Representative disclosed that they had sold between $1,001 and $15,000 in Zoetis stock on October 2nd. The trade occurred in the Representative’s “MORAN WEALTH IRA” account.

Representative Byron Donalds also recently made the following trade(s):

  • Purchased $1,001 – $15,000 in shares of Interactive Brokers Group (NASDAQ:IBKR) on 10/2/2026.
  • Sold $1,001 – $15,000 in shares of Autodesk (NASDAQ:ADSK) on 10/2/2026.
  • Sold $1,001 – $15,000 in shares of Netflix (NASDAQ:NFLX) on 10/2/2026.

Zoetis Stock Down 1.3%

ZTS opened at $83.32 on Wednesday. Zoetis Inc. has a one year low of $68.77 and a one year high of $132.49. The company has a market cap of $33.85 billion, a price-to-earnings ratio of 14.17, a PEG ratio of 1.22 and a beta of 0.67. The business’s fifty day moving average is $76.64 and its two-hundred day moving average is $91.18. The company has a debt-to-equity ratio of 2.51, a quick ratio of 1.40 and a current ratio of 2.35.

Zoetis (NYSE:ZTS – Get Free Report) last announced its earnings results on Thursday, November 5th. The company reported $1.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.24. Zoetis had a net margin of 26.15% and a return on equity of 85.90%. The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.30 billion. During the same quarter in the previous year, the business posted $1.70 earnings per share. The firm’s quarterly revenue was down 1.3% compared to the same quarter last year. Analysts anticipate that Zoetis Inc. will post 6.29 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 1st. Stockholders of record on Friday, October 30th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Friday, October 30th. Zoetis’s dividend payout ratio (DPR) is presently 36.05%.

Wall Street Analysts Forecast Growth

ZTS has been the topic of several recent research reports. Piper Sandler reduced their price objective on Zoetis from $90.00 to $80.00 and set a “neutral” rating on the stock in a research report on Monday, August 10th. The Goldman Sachs Group began coverage on Zoetis in a research report on Friday, October 16th. They set a “neutral” rating and a $74.00 price objective for the company. TD Cowen dropped their price objective on Zoetis from $104.00 to $94.00 and set a “buy” rating for the company in a research report on Tuesday, August 25th. BNP Paribas Exane cut their target price on shares of Zoetis from $146.00 to $110.00 and set an “outperform” rating for the company in a research note on Tuesday, August 11th. Finally, BTIG Research dropped coverage on shares of Zoetis in a report on Friday, October 30th. They issued a “buy” rating and a $200.00 target price on the stock. Eight analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $101.25.

View Our Latest Research Report on Zoetis

Hedge Funds Weigh In On Zoetis

A number of institutional investors and hedge funds have recently made changes to their positions in ZTS. Cassaday & Co Wealth Management LLC purchased a new stake in Zoetis during the 1st quarter valued at about $28,000. Wellington Grp LLC raised its holdings in Zoetis by 6,675.0% in the 1st quarter. Wellington Grp LLC now owns 271 shares of the company’s stock worth $32,000 after acquiring an additional 267 shares during the last quarter. University of Texas Texas AM Investment Management Co. bought a new position in Zoetis in the 2nd quarter valued at approximately $25,000. Dunhill Financial LLC lifted its position in Zoetis by 519.3% in the 2nd quarter. Dunhill Financial LLC now owns 353 shares of the company’s stock valued at $25,000 after acquiring an additional 296 shares in the last quarter. Finally, Dakota Community Bank & Trust NA boosted its stake in Zoetis by 112.4% during the 1st quarter. Dakota Community Bank & Trust NA now owns 393 shares of the company’s stock valued at $46,000 after purchasing an additional 208 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

About Representative Donalds

Byron Donalds (Republican Party) is a member of the U.S. House, representing Florida’s 19th Congressional District. He assumed office on January 3, 2021. His current term ends on January 3, 2027.

Donalds (Republican Party) is running for re-election to the U.S. House to represent Florida’s 19th Congressional District. He declared candidacy for the 2026 election.

Byron Donalds was born in Brooklyn, New York, and lives in Naples, Florida. Donalds earned a bachelor’s degree in finance and marketing from Florida State University in 2002. His career experience includes working as a commercial credit officer in banking and as a portfolio manager in financial services.

Zoetis Company Profile

(Get Free Report)

Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company’s offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world.

Read More

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.